N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease.
3CL(pro)
Covalent reversible inhibitors
SARS-CoV-2
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
24 Jul 2024
24 Jul 2024
Historique:
received:
13
06
2024
revised:
16
07
2024
accepted:
22
07
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
28
7
2024
Statut:
aheadofprint
Résumé
The 3CL protease (3CL
Identifiants
pubmed: 39068863
pii: S0223-5234(24)00587-7
doi: 10.1016/j.ejmech.2024.116707
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116707Informations de copyright
Copyright © 2024. Published by Elsevier Masson SAS.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.